We would like to take this opportunity to express our sincere gratitude for your support and patronage.
As a publicly traded company, we are fully aware of our responsibility. We, the board of directors and all employees, will work together as one to further expand our business and become a company that is trusted by all stakeholders and that can contribute to society at large.
Heartseed Inc. is a bio-venture company founded in November 2015, originating from Keio University. Cardiovascular disease is the leading cause of death in the world. With our mission of "Open the Door to the Treatment of Heart Disease through Regenerative Medicine," we are committed to realizing cardiac regenerative medicine for the treatment of advanced heart failure, one of the most serious cardiovascular diseases.
We sincerely appreciate your continued support and encouragement.
Heartseed Inc. CEO,
Representative Director of the Board
Keiichi FUKUDA, MD/PhD/FACC